FDA Approves New Anti-Abuse Label for Embeda October 17, 2014 Pat Anson, Editor The Food and Drug Administration has approved new labeling for Pfizer’s Embeda extended-release capsules, an opioid pain reliever that combines morphine with naltrexone to discourage…